chr10-123051072-C-T

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS1

The NM_001609.4(ACADSB):​c.1014C>T​(p.His338His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00033 in 1,612,024 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00023 ( 0 hom. )

Consequence

ACADSB
NM_001609.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -3.24

Publications

1 publications found
Variant links:
Genes affected
ACADSB (HGNC:91): (acyl-CoA dehydrogenase short/branched chain) Short/branched chain acyl-CoA dehydrogenase(ACADSB) is a member of the acyl-CoA dehydrogenase family of enzymes that catalyze the dehydrogenation of acyl-CoA derivatives in the metabolism of fatty acids or branch chained amino acids. Substrate specificity is the primary characteristic used to define members of this gene family. The ACADSB gene product has the greatest activity towards the short branched chain acyl-CoA derivative, (S)-2-methylbutyryl-CoA, but also reacts significantly with other 2-methyl branched chain substrates and with short straight chain acyl-CoAs. The cDNA encodes for a mitochondrial precursor protein which is cleaved upon mitochondrial import and predicted to yield a mature peptide of approximately 43.7-KDa. [provided by RefSeq, Jul 2008]
ACADSB Gene-Disease associations (from GenCC):
  • 2-methylbutyryl-CoA dehydrogenase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 10-123051072-C-T is Benign according to our data. Variant chr10-123051072-C-T is described in ClinVar as Benign. ClinVar VariationId is 536348.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.24 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00134 (203/151900) while in subpopulation AFR AF = 0.0042 (174/41434). AF 95% confidence interval is 0.00369. There are 0 homozygotes in GnomAd4. There are 96 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACADSBNM_001609.4 linkc.1014C>T p.His338His synonymous_variant Exon 9 of 11 ENST00000358776.7 NP_001600.1 P45954-1A0A0S2Z3P9
ACADSBNM_001330174.3 linkc.708C>T p.His236His synonymous_variant Exon 8 of 10 NP_001317103.1 P45954-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACADSBENST00000358776.7 linkc.1014C>T p.His338His synonymous_variant Exon 9 of 11 1 NM_001609.4 ENSP00000357873.3 P45954-1
ACADSBENST00000368869.8 linkc.708C>T p.His236His synonymous_variant Exon 8 of 10 2 ENSP00000357862.4 P45954-2

Frequencies

GnomAD3 genomes
AF:
0.00134
AC:
204
AN:
151788
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00424
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00145
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000286
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.000960
GnomAD2 exomes
AF:
0.000403
AC:
101
AN:
250854
AF XY:
0.000317
show subpopulations
Gnomad AFR exome
AF:
0.00383
Gnomad AMR exome
AF:
0.000463
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000925
Gnomad NFE exome
AF:
0.000141
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000225
AC:
329
AN:
1460124
Hom.:
0
Cov.:
31
AF XY:
0.000205
AC XY:
149
AN XY:
726348
show subpopulations
African (AFR)
AF:
0.00377
AC:
126
AN:
33432
American (AMR)
AF:
0.000515
AC:
23
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26116
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.0000929
AC:
8
AN:
86118
European-Finnish (FIN)
AF:
0.000131
AC:
7
AN:
53382
Middle Eastern (MID)
AF:
0.000642
AC:
3
AN:
4676
European-Non Finnish (NFE)
AF:
0.000114
AC:
127
AN:
1111772
Other (OTH)
AF:
0.000581
AC:
35
AN:
60242
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
17
34
52
69
86
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00134
AC:
203
AN:
151900
Hom.:
0
Cov.:
31
AF XY:
0.00129
AC XY:
96
AN XY:
74226
show subpopulations
African (AFR)
AF:
0.00420
AC:
174
AN:
41434
American (AMR)
AF:
0.00144
AC:
22
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5152
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4806
European-Finnish (FIN)
AF:
0.000286
AC:
3
AN:
10504
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
67984
Other (OTH)
AF:
0.000951
AC:
2
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
9
19
28
38
47
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000604
Hom.:
0
Bravo
AF:
0.00164
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000237

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Deficiency of 2-methylbutyryl-CoA dehydrogenase Benign:2
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Jan 09, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
0.29
DANN
Benign
0.55
PhyloP100
-3.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs57339164; hg19: chr10-124810588; API